Apollo Hospitals Enterprise Limited is an Indian multinational healthcare group headquartered in Chennai. Apart from the eponymous hospital chain, the company also operates pharmacies, primary care and diagnostic centres, and telehealth clinics through its subsidiaries.

During the past decade, Apollo Hospitals conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 7 clinical trials were completed, i.e. on average, 58.3% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 4 clinical trials were completed. i.e. 44.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Apollo Hospitals" #1 sponsor was "Abbott Medical Devices" with 6 trials, followed by "United Therapeutics" with 3 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "Kowa Research Europe" with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Apollo Hospitals" #1 collaborator was "Aalborg University Hospital" with 1 trials as a collaborator, "Aarhus University Hospital" with 1 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Apollo Hospitals Enterprise Limited" with 1 trials as a collaborator and "Asian Clinical Trials" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Apollo Hospitals" are "Coronary Artery Disease" (3 trials), "Pulmonary Arterial Hypertension" (3 trials), "Cardiovascular Diseases" (2 trials), "Dyslipidemia" (2 trials) and "Acquired Hemophilia A" (1 trials). Many other conditions were trialed in "Apollo Hospitals" in a lesser frequency.

Most popular intervention types in "Apollo Hospitals" are "Drug" (14 trials), "Device" (6 trials), "Biological" (1 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Pitavastatin" (2 trials), "3T MRI scan" (1 trials), "Atorvastatin" (1 trials), "BIBF 1120 plus docetaxel" (1 trials) and "Bevacizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Apollo Hospitals" are 26 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Apollo Hospitals". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Apollo Hospitals, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Apollo Hospitals, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 4 trials that are defined as “Not Applicable".

Apollo Hospitals has several departments that took part in Clinical trials: "Apollo Gleneagles Cancer Hospital" - 3 trials